USPTO serial 90520968
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
PerkinElmer chemagen Technologie GmbH
Baesweiler, DE
Other trademarks owned by PerkinElmer chemagen Technologie GmbH
REVVITY CHEMAGEN TECHNOLOGIE GMBH
BAESWEILER, DE
PerkinElmer chemagen Technologie GmbH
Baesweiler, DE
Other trademarks owned by PerkinElmer chemagen Technologie GmbH
PerkinElmer chemagen Technologie GmbH
Baesweiler, DE
Other trademarks owned by PerkinElmer chemagen Technologie GmbH
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin Oliver
Kevin Oliver PERKINELMER, INC.940 WINTER STREETWALTHAM, MA 02451UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays and reagents for use in genetic research; Assays for research purposes; Biochemical reagents used for non-medical purposes; Chemicals for use in the purification of proteins for in vitro use; Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Protein arrays and nucleotide arrays for scientific and medical research; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Reagents for scientific and research use; Reagents for scientific or medical research use; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Diagnostic reagents for scientific or research use; Diagnostic reagents for clinical or medical laboratory use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Reagents for testing food, other than for medical or veterinary use | ACTIVE | — |
| 005 | Diagnostic preparations for medical purposes; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Protein arrays for medical diagnosis purposes; Reagents for medical use; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Medical diagnostic reagents and assays for testing of body fluids | ACTIVE | Feb 25, 2019 |
| 009 | Computer software platforms, downloadable, for scientific analysis in the field of nucleic acid analysis; Computer software platforms, recorded, for scientific analysis in the field of nucleic acid analysis; Laboratory apparatus and computer systems for use in protein purification; Laboratory apparatus and instruments for extracting DNA; Laboratory apparatus and instruments for extracting nucleic acid; Laboratory chemical reactors; Laboratory devices for detecting genetic sequences; Laboratory equipment and supplies, namely, test tubes; Magnetic separators for scientific use; Medical laboratory research instruments for DNA analysis; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Scientific instrumentation for measuring proteins; Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of biologics; Diagnostic apparatus for testing food; Downloadable computer software for scientific analysis of genetic sequences; Laboratory consumables, namely, pipette tips | ACTIVE | — |
| 010 | Apparatus for DNA and RNA testing for medical purposes; Blood testing apparatus; Medical diagnostic instruments for the analysis of body fluids; Sample preparation device for medical diagnostic uses; Medical diagnostic apparatus for testing DNA and RNA samples | ACTIVE | Feb 25, 2019 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 13, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 26, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 26, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 21, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jun 19, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 15, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 15, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 27, 2022 | IUAF | USE AMENDMENT FILED | — |
| May 27, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 7, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 12, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 12, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 22, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 3, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 3, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 3, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 3, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 2, 2021 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Sep 2, 2021 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Sep 2, 2021 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Sep 2, 2021 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Sep 2, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 14, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 12, 2021 | NWAP | NEW APPLICATION ENTERED | — |